Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 11, 2024
With
the
passage
of
time,
people
step
toward
old
age
and
become
more
prone
to
several
diseases
associated
with
age.
One
such
is
Alzheimer's
disease
(AD)
which
results
into
neuronal
damage
dementia
progression
The
existing
therapeutics
has
been
hindered
by
various
enkindles
like
less
eminent
between
remote
populations,
affordability
issues
toxicity
profiles.
Moreover,
lack
suitable
therapeutic
option
further
worsens
quality
life
in
older
population.
Developing
an
efficient
intervention
cure
AD
still
a
challenge
for
medical
fraternity.
Recently,
alternative
approaches
attain
attention
researchers
focus
on
plant-based
therapy
mitigating
AD.
In
this
context,
flavonoids
gained
centrality
as
feasible
treatment
modifying
neurological
deficits.
This
review
mainly
focuses
pathological
facets
economic
burden
Furthermore,
we
have
explored
possible
mechanism
preclinical
clinical
aspects
curing
Flavonoids
being
potential
therapeutic,
target
pathogenic
factors
oxidative
stress,
inflammation,
metal
toxicity,
Aβ
accumulation,
modulate
neurotransmission
insulin
signaling.
review,
emphasized
neuroprotective
effects
pathology,
both
experimental
findings.
While
studies
suggest
promising
benefits,
data
remains
limited
inconclusive.
Thus,
high-quality
trials
are
necessary
validate
efficacy
study
aim
promote
therapies
encourage
add
regular
diet
avail
beneficial
preventive
Ecotoxicology and Environmental Safety,
Journal Year:
2024,
Volume and Issue:
285, P. 117148 - 117148
Published: Oct. 1, 2024
Kashin-Beck
disease
(KBD)
is
an
endemic
osteoarthropathy
characterized
by
excessive
chondrocytes
apoptosis.
T-2
toxin
exposure
has
been
proved
to
be
its
etiology.
Connective
tissue
growth
factor
(CTGF)
exerts
a
profound
influence
on
cartilage
and
metabolism.
We
investigated
the
potential
role
of
CTGF
in
KBD
development
examined
alterations
under
stimulation.
Journal of Alzheimer s Disease,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 10, 2024
Alzheimer's
disease
(AD)
is
characterized
by
neurodegeneration
linked
to
amyloid-β
(Aβ)
plaques
and
tau
protein
tangles.
Protein
kinase
C
alpha
(PKCα)
plays
a
crucial
role
in
modulating
precursor
(AβPP)
processing,
potentially
mitigating
AD
progression.
Consequently,
PKCα
stands
out
as
promising
target
for
therapy.